v3.23.3
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Operating activities:      
Net increase (decrease) in net assets resulting from operations $ 117,331 $ 29,223 $ 237,260
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Net unrealized (appreciation) depreciation 28,555 136,248 (114,519)
Net realized (gains) losses 33,155 (17,179) (26,420)
PIK interest income (19,764) (20,526) (16,447)
Accretion of original issue discount on investments (22,314) (29,091) (29,391)
Accretion of original issue discount on unsecured notes payable 783 679 572
Amortization of deferred financing costs 4,599 3,740 4,151
Deferred taxes 1,670 (973) 133
Purchases of investments (742,144) (702,063) (1,120,168)
Proceeds from the sales and repayments of investments 911,975 693,745 792,161
Cash received from mergers 22,317 0 20,945
Changes in operating assets and liabilities:      
(Increase) decrease in interest, dividends and fees receivable 578 (16,115) (8,495)
(Increase) decrease in due from portfolio companies 16,283 (20,505) 1,360
(Increase) decrease in receivables from unsettled transactions (50,742) 3,458 2,514
(Increase) decrease in due from broker (8,730) (43,890) (1,640)
(Increase) decrease in other assets 14 619 (1,427)
Increase (decrease) in accounts payable, accrued expenses and other liabilities (53,118) 677 (426)
Increase (decrease) in base management fee and incentive fee payable (489) (16,709) 19,516
Increase (decrease) in due to affiliate 408 (1,177) 1,119
Increase (decrease) in interest payable 4,379 3,339 1,163
Increase (decrease) in payables from unsettled transactions (15,975) 18,895 7,608
Increase (decrease) in director fees payable (9) 0 (90)
Net cash provided by (used in) operating activities 228,762 22,395 (230,521)
Financing activities:      
Distributions paid in cash (180,046) (115,248) (79,850)
Borrowings under credit facilities 572,000 300,000 505,000
Repayments of borrowings under credit facilities (787,000) (230,000) (529,582)
Issuance of unsecured notes 296,511 0 349,020
Repayments of secured borrowings 0 0 (9,341)
Shares issued under the "at the market" offering 1,370 20,839 0
Repurchases of common stock under dividend reinvestment plan (2,418) (1,857) (2,170)
Deferred financing costs paid (10,596) (334) (8,890)
Offering costs paid (235) (215) 0
Net cash provided by (used in) financing activities (110,414) (26,815) 224,187
Effect of exchange rate changes on foreign currency 827 (851) (1,127)
Net increase (decrease) in cash and cash equivalents and restricted cash 119,175 (5,271) (7,461)
Cash and cash equivalents and restricted cash, beginning of period 26,364 31,635 39,096
Cash and cash equivalents and restricted cash, end of period 145,539 26,364 31,635
Supplemental information:      
Cash paid for interest 98,189 39,171 24,006
Non-cash financing activities:      
Issuance of shares of common stock under dividend reinvestment plan 3,436 3,409 2,170
Deferred financing costs 442 0 (162)
Deferred offering costs 12 0 0
Issuance of shares in connection with mergers 334,034 0 242,704
Reconciliation to the Consolidated Statements of Assets and Liabilities      
Cash and cash equivalents 136,450 23,528 29,334
Restricted cash 9,089 2,836 2,301
Total cash and cash equivalents and restricted cash $ 145,539 $ 26,364 $ 31,635